Anixa Biosciences, Inc.ANIXNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank79
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P79
Within normal range
Average
-1594.91%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%+100.0%
2023-5221.43%-
20220.00%+100.0%
2021-2554.94%-
20200.00%+100.0%
2019-4401.98%-252.3%
2018-1249.38%-9.4%
2017-1142.08%+17.2%
2016-1379.28%-